Team:Freiburg/Content/Results/Summary

From 2014.igem.org

(Difference between revisions)
 
(2 intermediate revisions not shown)
Line 48: Line 48:
               <div id="content-lightbox" data-target="#over-right" style="display:none;">
               <div id="content-lightbox" data-target="#over-right" style="display:none;">
<img class="img-no-pad" src="https://static.igem.org/mediawiki/2014/4/4b/2014Freiburg_Lichtbox_summary.JPG" alt="Description of Image">
<img class="img-no-pad" src="https://static.igem.org/mediawiki/2014/4/4b/2014Freiburg_Lichtbox_summary.JPG" alt="Description of Image">
-
<p class="small" style="line-height: 130%; padding-top: 10px;">To illuminate our cells, we build our own light boxes. Here you can see the inner life of our box for an illumination with light of the wavelength of 465 nm </p>
+
<p class="small" style="line-height: 130%; padding-top: 10px;">To illuminate our cells, we build our own light boxes. Here you can see the inner life of our box for an illumination with light of the wavelength of 465 nm.</p>
               </div>
               </div>
               <div id="content-vector" data-target="#over-left" style="display:none;">
               <div id="content-vector" data-target="#over-left" style="display:none;">
<img class="img-no-pad" src="https://static.igem.org/mediawiki/2014/b/b7/Freiburg2014-09-24_NIH3t3_transduced_with_MuLV_EGFP_header_Summary_Thumbnail.jpg">
<img class="img-no-pad" src="https://static.igem.org/mediawiki/2014/b/b7/Freiburg2014-09-24_NIH3t3_transduced_with_MuLV_EGFP_header_Summary_Thumbnail.jpg">
-
<p class="small" style="line-height: 130%; padding-top: 10px;">We generated a viral vector based on the Murine Leukemia Virus (MuLV) that stably integrates DNA into the genome of mammalian target cells. We optimized the transduction efficiency to almost 100%. We demonstrated that.</p>
+
<p class="small" style="line-height: 130%; padding-top: 10px;">We generated a viral vector based on the Murine Leukemia Virus (MuLV) that stably integrates DNA into the genome of mammalian target cells. We optimized the transduction efficiency to almost 100%.</p>
               </div>
               </div>
               <div id="content-combination" data-target="#over-right" style="display:none;">
               <div id="content-combination" data-target="#over-right" style="display:none;">
Line 76: Line 76:
Our project was quite a large success! We:
Our project was quite a large success! We:
</p>
</p>
 +
<em>
<ul>
<ul>
<li>produced MuLV viruses containing different reporter proteins,</li>
<li>produced MuLV viruses containing different reporter proteins,</li>
Line 83: Line 84:
<li>demonstrated that the virus exclusively infects cells expressing the mCAT-1 receptor,</li>
<li>demonstrated that the virus exclusively infects cells expressing the mCAT-1 receptor,</li>
<li>infected cells with the MuLV virus that expressed the mCAT-1 receptor after light induction.</li>
<li>infected cells with the MuLV virus that expressed the mCAT-1 receptor after light induction.</li>
-
</ul>
+
</ul>
 +
</em>
<br/ >
<br/ >
Line 104: Line 106:
<li>creating a website,</li>
<li>creating a website,</li>
</ul>
</ul>
-
 
+
<br/ >
<p>
<p>
and, last but not least, we had a lot of fun and learned how to work together as a team!
and, last but not least, we had a lot of fun and learned how to work together as a team!

Latest revision as of 03:32, 18 October 2014

The AcCELLerator

Summary



We, the iGEM Team Freiburg 2014, have the goal to combine the capability of viral vectors for stable gene transfer with the spatio-temporal resolution of optogenetics for gene delivery into mammalian cells. We utilized the Murine Leukemia Virus (MuLV) that specifically uses the murine mCAT-1 receptor to infect target cells. By using a blue light inducible expression system, we brought the receptor to the plasma membrane of illuminated cells to enable targeted gene delivery by the virus.

Our project was quite a large success! We:

  • produced MuLV viruses containing different reporter proteins,
  • optimized MuLV production and transduction protocols to reach close to 100% efficiency,
  • created stable mammalian cell lines using the MuLV virus,
  • generated patterns of reporter proteins in cell cultures by light exposure,
  • demonstrated that the virus exclusively infects cells expressing the mCAT-1 receptor,
  • infected cells with the MuLV virus that expressed the mCAT-1 receptor after light induction.

We provide the virus as a tool for the generation of stable mammalian cell lines under biosafety level 1 regulations. Our viral vector, which we propose as a new iGEM RFC, enables the user to introduce any gene of interest stably into mammalian cell lines. Therefore we provide for the iGEM community a fast, easy to handle and safe way of generating stable cell lines.

During the course of iGEM, we learned many new techniques:

  • mammalian cell culture,
  • fluorescence activated cell sorting,
  • virus production under biosafety level 1 and biosafety level 2 conditions,
  • many different cloning techniques,
  • widefield and confocal microscopy,
  • creating a website,

and, last but not least, we had a lot of fun and learned how to work together as a team!